About Unlearn.AI
Unlearn.AI uses AI to create digital twins of clinical trial participants, streamlining clinical development and enabling confident decision-making.
Mission & Story
Mission
Driving clarity in clinical development. Powered by digital twins, data, and AI. Unlearn integrates the evidence, modeling, and reasoning behind decisions, so trial teams can commit with confidence, and so each decision builds on the last.
Founding Story
Founded by Aaron Smith (Head of AI) and Jon Walsh (Chief Scientific Officer). The company emerged from research on using machine learning to model disease progression and generate digital twins of patients for clinical trials.
Clinical Focus
Medical conditions and clinical areas addressed by Unlearn.AI.
Who It Serves
Milestones & Awards
Recent Milestones
January 2026: Introduced TrialPioneer AI-powered workspace for upstream trial planning. February 2026: Partnership with VectorY Therapeutics for PIONEER-ALS Study. April 2025: Partnership with remynd for Alzheimer's study. April 2025: Partnership with Trace Neuroscience for ALS trial optimization. September 2024: ProJenX partnership for ALS trial.
Awards & Recognition
EMA qualification of PROCOVA method for Phase 2 and 3 trials. FDA positive feedback on PROCOVA methodology.
Key Partnerships
Social & Media
Follow on
Company Details
- Founded
- 2017
- Headquarters
- San Francisco, CA, USA
- Employees
- 72
- Stage
- series c
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 42 →
AiCure
AiCure provides H.Code, an AI-powered patient engagement platform for clinical trials that uses computer vision, predictive analytics, and mobile technology to verify medication adherence, reduce dropout rates, and improve trial data quality for pharmaceutical companies, CROs, and clinical sites.
Antidote
Antidote connects patients with clinical trials through precision recruitment services and their Match search engine. They help pharmaceutical sponsors accelerate enrollment while making it easier for patients to find relevant research opportunities.
BEKhealth
BEKhealth transforms structured and unstructured EHR data into clinical intelligence for trial recruitment and real-world evidence. The platform uses AI to match patients to complex trial criteria in minutes and generates longitudinal real-world data across 30M+ patients and 200+ research sites.
BenevolentAI
public · 180 employees
BenevolentAI unites AI and cutting-edge science to discover and develop new medicines, leveraging a knowledge graph and proprietary ontologies.
Biorce
Biorce develops Aika, an explainable AI platform that accelerates clinical trial design, feasibility assessment, and regulatory planning. The platform helps pharmaceutical companies and CROs reduce trial setup time by 90%, prevent costly protocol amendments, and bring treatments to patients faster.
BIOS Health
BIOS Health develops neural interfaces and AI platforms that read and write the body's neural data to understand and correct signals in real-time. The company enables neural digital therapies for chronic diseases through biomarker discovery and personalized dosing optimization.
Castor
Castor provides an integrated eClinical platform for clinical trials and research, offering EDC, eCOA/ePRO, eConsent, and DCT solutions. The company serves biopharma, CROs, medical device companies, and academic researchers across 100+ countries with over 2,500 commercial trials.
Circuit Clinical
Circuit Clinical is an Integrated Research Organization (IRO) that brings clinical trials directly into community healthcare settings. They partner with physicians, health systems, and FQHCs to expand access to clinical research in historically underrepresented communities across the United States.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.